title: Complementary data about the inhibitory effects of intravenous immunoglobulins in vitro and in vivo.
authors.forename: D H
authors.initials: DH
authors.lastname: Casadei
authors.forename: M C
authors.initials: MC
authors.lastname: Rial
authors.forename: E
authors.initials: E
authors.lastname: Raimondi
authors.forename: J
authors.initials: J
authors.lastname: Goldberg
authors.forename: J
authors.initials: J
authors.lastname: Argento
authors.forename: E
authors.initials: E
authors.lastname: Haas
mesh_terms: D000328:Adult; D003520:Cyclophosphamide / Q000037:antagonists & inhibitors*; D016572:Cyclosporine / Q000037:antagonists & inhibitors*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D066298:In Vitro Techniques; D016030:Kidney Transplantation / Q000276:immunology; D008875:Middle Aged
chemical_list: D016756:Immunoglobulins, Intravenous; D016572:Cyclosporine; D003520:Cyclophosphamide